文献速递糖尿病

香港糖尿病成人2002-2016年降糖药使用、血糖控制与严重低血糖趋势

Trends in Glucose-Lowering Drug Use, Glycemic Control, and Severe Hypoglycemia in Adults With Diabetes in Hong Kong, 2002-2016.
PubMed 文献 · Diabetes Care · 2020-10-12

该研究基于香港糖尿病监测数据库,分析2002-2016年763,809例≥20岁糖尿病患者的降糖药使用、HbA1c水平及严重低血糖发生率。结果显示磺脲类使用下降、二甲双胍和DPP-4抑制剂上升,HbA1c 6.0-7.0%比例增加,严重低血糖率下降,但年轻组血糖控制差且未用药比例上升。

要点

  • 磺脲类使用从62.9%降至35.3%,二甲双胍从48.4%升至61.4%,DPP-4抑制剂从0.01%升至8.3%。
  • HbA1c 6.0-7.0%比例从28.6%升至43.4%,严重低血糖率从4.2/100人年降至1.3/100人年。
  • 20-44岁组HbA1c≥9%比例最高,未使用降糖药比例从2.0%升至7.7%。

核心结论

  • 2007年以来HbA1c适度改善与糖尿病服务改革、二甲双胍增加、磺脲类减少及DPP-4抑制剂适度上升同步。
  • 最年轻组持续血糖控制不佳且降糖药使用不足,需针对性干预。

研究设计与样本

  • 基于香港糖尿病监测数据库的人群为基础调查,纳入763,809例≥20岁糖尿病患者,分析2002-2016年趋势。

主要发现

  • 磺脲类使用从62.9%降至35.3%,二甲双胍从48.4%升至61.4%,DPP-4抑制剂从2007年0.01%升至8.3%。
  • HbA1c 6.0-7.0%(42-53 mmol/mol)比例从28.6%升至43.4%,严重低血糖率从4.2/100人年降至1.3/100人年。
  • HbA1c主要改善在2007-2014年,均值(SD)从7.6%(1.6)(59.5 [19.0] mmol/mol)降至7.2%(1.7)(54.8 [18.9] mmol/mol)(P < 0.001)。
  • 20-44岁组HbA1c≥9%(75 mmol/mol)比例最高,未使用降糖药比例从2.0%升至7.7%。

临床怎么用

  • 关注年轻糖尿病患者降糖药使用不足和血糖控制差的问题,实施针对性管理。
  • 持续监测降糖药使用模式与严重低血糖发生率,评估糖尿病服务改革效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: There has been a shift toward new classes of glucose-lowering drugs (GLDs) in the past decade but no improvements in glycemic control or hospitalization rates due to severe hypoglycemia (SH) in previous surveys. We examined trends in GLDs use, glycemic control, and SH rate among patients with diabetes in Hong Kong, which introduced a territory-wide, team-based diabetes care model since 2000. RESEARCH DESIGN AND METHODS: Using population-based data from the Hong Kong Diabetes Surveillance Database, we estimated age- and sex-standardized proportion of GLD classes, mean hemoglobin A1c (HbA1c) levels, and SH rates in 763,809 patients with diabetes aged ≥20 years between 2002 and 2016. RESULTS: Between 2002 and 2016, use declined for sulfonylureas (62.9% to 35.3%) but increased for metformin (48.4% to 61.4%) and dipeptidyl peptidase 4 inhibitors (DPP-4is) (0.01% in 2007 to 8.3%). The proportion of patients with HbA1c of 6.0-7.0% (42-53 mmol/mol) increased from 28.6% to 43.4%, while the SH rate declined from 4.2/100 person-years to 1.3/100 person-years. The main improvement in HbA1c occurred between 2007 and 2014, decreasing from mean (SD) 7.6% (1.6) (59.5 [19.0] mmol/mol) to 7.2% (1.7) (54.8 [18.9] mmol/mol) (P < 0.001). The 20-44 years age-group had the highest proportion of HbA1c ≥9% (75 mmol/mol) and rising proportions not on GLDs (from 2.0% to 7.7%). CONCLUSIONS: In this 15-year survey, the modest but important improvement in HbA1c since 2007 coincided with diabetes service reforms, increase in metformin, decrease in sulfonylureas, and modest rise in DPP-4i use. Persistently poor glycemic control and underuse of GLDs in the youngest group calls for targeted action.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Yang A, Wu H, Lau ESH, et al. Trends in Glucose-Lowering Drug Use, Glycemic Control, and Severe Hypoglycemia in Adults With Diabetes in Hong Kong, 2002-2016. Diabetes Care. 2020. PMID: 33046501. doi:10.2337/dc20-0260

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。